Use of Finasteride in the Treatment of Men With Androgenetic Alopecia (Male Pattern Hair Loss)  Jerry Shapiro, Keith D. Kaufman  Journal of Investigative Dermatology Symposium Proceedings  Volume 8, Issue 1, Pages 20-23 (June 2003) DOI: 10.1046/j.1523-1747.2003.12167.x Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Finasteride treatment led to no further visible hair loss from baseline in the majority of men over 5 years of observation, based on expert panel review of standardized clinical photographs for the cohort of patients in the combined Phase III vertex hair loss studies who entered the last (fifth) placebo-controlled extension studies. Conversely, most (75%) men treated with placebo sustained further visible hair loss at 5 years. Journal of Investigative Dermatology Symposium Proceedings 2003 8, 20-23DOI: (10.1046/j.1523-1747.2003.12167.x) Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Finasteride treatment led to a more positive self-assessment of scalp hair appearance compared with placebo over 5 years of observation. One-year and 5-year data are shown for the percent of men who self-reported their degree of satisfaction with the overall appearance of their scalp hair compared with baseline for the cohort of patients in the combined Phase III vertex hair loss studies who entered the last (fifth) placebo-controlled extension studies. Journal of Investigative Dermatology Symposium Proceedings 2003 8, 20-23DOI: (10.1046/j.1523-1747.2003.12167.x) Copyright © 2003 The Society for Investigative Dermatology, Inc Terms and Conditions